Mutation or loss of p53 differentially modifies TGFβ action in ovarian cancer.
Ovarian cancer is the most lethal gynecological disease affecting women in the US. The Cancer Genome Atlas Network identified p53 mutations in 96% of high-grade serous ovarian carcinomas, demonstrating its critical role. Additionally, the Transforming Growth Factor Beta (TGFβ) pathway is dysfunction...
Enregistré dans:
Auteurs principaux: | Eoghainín Ó hAinmhire, Suzanne M Quartuccio, Whay Cheng, Roshan A Ahmed, Shelby M King, Joanna E Burdette |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f96d07137ceb4af39b4e4d5c53e1082f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The action of ovarian hormones in cardiovascular disease
par: MEDINA,RODOLFO A, et autres
Publié: (2003) -
nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer
par: Ji-Hye Ahn, et autres
Publié: (2018) -
Expression of Fbxo7 in haematopoietic progenitor cells cooperates with p53 loss to promote lymphomagenesis.
par: Mikhail Lomonosov, et autres
Publié: (2011) -
Author Correction: nc886 is induced by TGF-β and suppresses the microRNA pathway in ovarian cancer
par: Ji-Hye Ahn, et autres
Publié: (2018) -
Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds
par: Burair A. Alsaihati, et autres
Publié: (2021)